Thursday, April 23, 2026

CATEGORY

Business

FSOC Rewrites Nonbank Regulation: Return to Activities-Based Oversight

FSOC votes to restore 2019 activities-based approach for designating systemically risky nonbanks, reversing Biden-era guidance in major regulatory shift.

FSOC 2026: AI, Deregulation, and New Direction for U.S. Financial Oversight

Treasury Secretary Bessent leads FSOC's shift from risk-first to growth-first regulation, targeting AI, private credit, and nonbank oversight reforms.

DART CEO Nadine Lee Resigns: What’s Next for Dallas Public Transit?

Nadine Lee resigns as DART CEO after 3+ years leading Dallas transit through post-pandemic challenges, leaving questions about the agency's future direction.

Pentagon Bets Big on Honeywell to Power Next-Gen Military Drones

The Pentagon is rapidly scaling autonomous drone and missile production, with Honeywell securing major contracts worth over $90B for next-gen warfare systems.

Pentagon, Lockheed & BAE to Quadruple THAAD Missile Production

Pentagon strikes deals with Lockheed Martin and BAE Systems to quadruple THAAD missile production to 400 units yearly, placing defense on wartime footing.

Oil Markets Surge Ahead of Trump-Iran Talks Post: Insider Trading Concerns Emerge

Oil futures spiked $580M in suspicious trades one minute before Trump's Iran peace post, raising insider trading concerns among legal experts.

Why Texas Leads US Business Growth: Innovation, Jobs & Opportunity

Governor Greg Abbott pitches Texas as America's top business hub at Fort Worth summit, touting record job growth and economic diversification.

Treasury Unveils New AI Guidelines to Secure US Banking Industry

U.S. Treasury releases AI risk framework for banks through public-private partnership, setting voluntary but influential standards for the financial sector.

Abbott Acquires Exact Sciences for $23B: Transforming Cancer Diagnostics

Abbott completes $23B acquisition of Exact Sciences, adding Cologuard and cancer diagnostics to dominate the $60B precision oncology market.

Abbott Acquires Exact Sciences for $21B: A Game Changer in Cancer Screening

Abbott acquires Exact Sciences for $21B to dominate cancer screening, combining Cologuard expertise with global diagnostics reach in bold M&A bet.

Latest news

- Advertisement -spot_img